Publications by authors named "Yasamin Azimi"

Claim this Profile
C
CRISPR/dCas9-TET1-mediated epigenetic editing reactivates miR-200c in breast cancer cells.
Mahyar Zahraei, Yasamin Azimi, Morteza Karimipour, Fatemeh Rahimi-Jamnani, Vahideh Valizadeh

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4.
Yasamin Azimi, Sara Hajibabaei, Ghazal Azimi, Fatemeh Rahimi-Jamnani, Masoumeh Azizi

Genes Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4.
Yasamin Azimi, Sara Hajibabaei, Ghazal Azimi, Fatemeh Rahimi-Jamnani, Masoumeh Azizi

Genes Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis.
Sara Hajibabaei, Nahid Nafissi, Yasamin Azimi, Reza Mahdian, Fatemeh Rahimi-Jamnani

Sci Rep· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis